RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Innovation Pharmaceuticals Stock

Innovation Pharmaceuticals Equity 2024

Innovation Pharmaceuticals Equity

2.04 M USD

Ticker

IPIX

ISIN

US45782D1000

WKN

A2DTBJ

In 2024, Innovation Pharmaceuticals's equity was 2.04 M USD, a -56.89% increase from the 4.73 M USD equity in the previous year.

Innovation Pharmaceuticals Aktienanalyse

What does Innovation Pharmaceuticals do?

Innovation Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of novel therapeutics in various areas of medicine. Founded in 2007 as Cellceutix Corporation, the company was renamed Innovation Pharmaceuticals Inc. in 2016. The goal of Innovation Pharmaceuticals is to meet the needs of patients suffering from rare or severe diseases by developing innovative therapies. The focus is on combating inflammation, infections, and cancer. The company's business model is to guide compounds through the stages of clinical development and then license or sell them to large pharmaceutical companies. The different divisions of Innovation Pharmaceuticals are diverse and encompass dermatology, oncology, and infectious diseases, among others. The company has a pipeline of products currently in clinical trials or nearing entry into the clinical phase. One of Innovation Pharmaceuticals' leading products is Brilacidin, a synthetic peptide that can be used as a broad-spectrum antibiotic as well as a potential drug for the treatment of inflammation and cancer. Brilacidin has shown promising results in clinical studies and is currently being investigated in various indications. Another promising product of Innovation Pharmaceuticals is Kevetrin, a drug used for the treatment of cancer. Kevetrin is unique as it focuses on the p53 tumor suppression mechanism. Kevetrin is currently in the clinical phase of development, and Innovation Pharmaceuticals has begun to explore its use in various types of cancer. Innovation Pharmaceuticals also has an extensive portfolio of compounds and technologies in the preclinical stage. These compounds have the potential to create new therapeutic options for various diseases, including autoimmune diseases, chronic inflammatory diseases, and infectious diseases. In summary, Innovation Pharmaceuticals Inc. is a leading biopharmaceutical company focusing on the development of innovative therapeutics in various areas of medicine. The company has an impressive pipeline of products and technologies at various stages of development that have shown promising results. Innovation Pharmaceuticals has the potential to significantly improve the lives of patients with rare and severe diseases by developing novel therapies that are currently unavailable. Innovation Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Innovation Pharmaceuticals's Equity

Innovation Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Innovation Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Innovation Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Innovation Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Innovation Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Innovation Pharmaceuticals stock

What is the equity of Innovation Pharmaceuticals this year?

Innovation Pharmaceuticals has equity of 2.04 M USD this year.

What was the equity of Innovation Pharmaceuticals compared to the previous year?

The equity of Innovation Pharmaceuticals has increased/decreased by -56.89% decreased compared to the previous year.

What impact does a high equity have on investors of Innovation Pharmaceuticals?

A high equity is advantageous for investors of Innovation Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Innovation Pharmaceuticals?

A low equity can be a risk for investors of Innovation Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Innovation Pharmaceuticals affect the company?

An increase in equity of Innovation Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Innovation Pharmaceuticals affect the company?

A reduction in equity of Innovation Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Innovation Pharmaceuticals?

Some factors that can affect the equity of Innovation Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Innovation Pharmaceuticals so important for investors?

The equity of Innovation Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Innovation Pharmaceuticals take to change the equity?

To change equity, Innovation Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Innovation Pharmaceuticals pay?

Over the past 12 months, Innovation Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovation Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Innovation Pharmaceuticals?

The current dividend yield of Innovation Pharmaceuticals is .

When does Innovation Pharmaceuticals pay dividends?

Innovation Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovation Pharmaceuticals?

Innovation Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Innovation Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovation Pharmaceuticals located?

Innovation Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Innovation Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovation Pharmaceuticals from 10/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/22/2024.

When did Innovation Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/22/2024.

What was the dividend of Innovation Pharmaceuticals in the year 2023?

In the year 2023, Innovation Pharmaceuticals distributed 0 USD as dividends.

In which currency does Innovation Pharmaceuticals pay out the dividend?

The dividends of Innovation Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innovation Pharmaceuticals

Our stock analysis for Innovation Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovation Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.